Humana Inc vs Lucid Group Inc — how do they compare? Humana Inc trades at $432.53 (market cap $46.49B), while Lucid Group Inc trades at $3.85 (market cap $1.51B). The key difference: Humana Inc is far larger — about 30.8× Lucid Group Inc's market cap, and Humana Inc pays a 0.91% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Lucid Group Inc for 45 Days on average.
| HUM | LCID | |
|---|---|---|
Market Cap | $46.49B | $1.51B |
Volume | 2,567,704 | 12,333,745 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $21.92 |
52-Week Low | $163.67 | $3.82 |
Typical Hold Time | 53 Days | 45 Days |
Enterprise Value | $53.84B | $4.40B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
Lucid Group (LCID) trades at $3.89, down 6.49% today, reflecting ongoing investor concerns about the company's financial health. The stock shows bearish technical signals with negative moving averages and faces significant fundamental challenges including massive losses, negative profit margins, and substantial cash burn. Recent developments include strategic partnerships for autonomous vehicles but also product delays and cost-cutting initiatives as the company navigates a critical turnaround phase.
LCID presents high-risk speculative potential with a consensus price target of $7.60 representing 95% upside, but faces existential challenges including potential bankruptcy risk, consistent earnings misses, and negative cash flow. The company's survival depends on successful execution of cost savings initiatives and new product launches, making this suitable only for risk-tolerant investors comfortable with substantial volatility and potential loss.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →